In Re Horizon/CMS Healthcare Corp. Securities Litigation

3 F. Supp. 2d 1208, 1998 U.S. Dist. LEXIS 5785, 1998 WL 230234
CourtDistrict Court, D. New Mexico
DecidedMarch 27, 1998
DocketCiv 96-442 BB/LCS
StatusPublished
Cited by12 cases

This text of 3 F. Supp. 2d 1208 (In Re Horizon/CMS Healthcare Corp. Securities Litigation) is published on Counsel Stack Legal Research, covering District Court, D. New Mexico primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Horizon/CMS Healthcare Corp. Securities Litigation, 3 F. Supp. 2d 1208, 1998 U.S. Dist. LEXIS 5785, 1998 WL 230234 (D.N.M. 1998).

Opinion

MEMORANDUM OPINION AND ORDER ALLOCATING ATTORNEYS’ FEES

BLACK, District Judge.

Justice William Brennan once noted that disputes over attorneys’ fees are “one of the least socially productive types of litigation imaginable.” Hensley v. Eckerhart, 461 U.S. 424, 442, 103 S.Ct. 1933, 76 L.Ed.2d 40 (1983) (Brennan, J., dissenting). Unfortunately, after obtaining a good settlement for the shareholders, the present litigation has degenerated into the type of public spectacle which has fueled the perception that the practice of law is no longer a learned profession but rather just another lucrative business.

Discussion

I.. The Factual Background of the Litigation

Horizon Healthcare Corporation, the predecessor to Horizon/CMS Healthcare Corporation (“Horizon” or the “Company”), provides acute rehabilitation and other services, long-term nursing care, contract rehabilitation, and other specialty healthcare services in several states. During the late 1980’s, Horizon embarked on an ambitious plan of growth-by-acquisition, expanding from 15 facilities in 1987 to nearly 100 facilities by mid-1993. In 1995, it acquired Continental Medical Systems (“CMS”) through a stock exchange. In November 1995, Horizon announced it would acquire Pacific Rehabilitation and Sports Medicine, Inc. (“Pacific Rehab”).

In December 1995, Horizon issued a press release in which it reported “record” earnings for the second quarter ending November 30, 1995. Horizon’s stock price climbed from $18 per share on June 6,1995, to a high of $28-1/8 per share in January 1996. In early February 1996, Business Week reported that the Company had been overstating its operating income and that Horizon’s historical results may have been inflated by aggressive accounting. Horizon’s stock price dropped $2 per share, before the Company responded with a denial. On March 1, 1996, Horizon revealed that the Company earnings for the next two fiscal quarters would be significantly lower than had been projected. After these disclosures, the market price of Horizon’s common stock fell $5.62, to $17.87 per share.

After the close of the trading day on March 15, 1996, Horizon disclosed that there was an on-going investigation of Horizon by the Office of the Inspector General and the Department of Justice stemming from alleged retroactive Medicare over-billings by a Company subsidiary. The press release issued by Horizon stated that the over-billings were estimated at $3,400,000. When trading resumed on Monday, March 18, 1996, Horizon’s share price fell from approximately $16.25 to $12.75 per share. Over the following 90 days, the average price of Horizon stock was $13.87.

In April, Horizon announced that a planned $200,000,000 debt offering had been put on hold, and that the Pacific Rehab acquisition had been abandoned. Beginning on April 2, 1996, twelve lawsuits were filed in the United States District Court for the District of New Mexico seeking class certification on behalf of: (1) all persons who purchased Horizon’s stock between June 6,1995, and March 15,1996, and who suffered a loss; and (2) those shareholders of CMS who acquired Horizon’s shares on or about July 10, 1995, in connection with the acquisition of CMS.

The complaints allege, inter alia, that Horizon and certain of its officers and directors (the “Individual Defendants”) violated the securities laws of the United States and New Mexico by disseminating false and misleading statements concerning Horizon and its operations, and that certain of the Individual Defendants had engaged in unlawful insider trading of Horizon stock, consisting of sales of over 1,500,000 shares for proceeds of approximately $40,000,000. The complaints seek relief on basically two claims: (1) that shareholders were not told about the retroactive Medicare billing investigation, and (2) that open market purchasers of Horizon *1211 shares were deceived because .the Company’s business was deteriorating and the Company hid its problems until the insider sales were completed.

In accordance with the Private Securities Litigation Reform Act of 1995, 15 U-S.C. chap.. 2A, § 77z~l, Plaintiffs’ counsel placed notices on national business wire services and in national business publications. Motions for appointment of lead Plaintiffs and for approval of lead counsel were filed with the Court. A group of eighteen Plaintiffs in nine related actions representing 42,855 shares of Horizon stock (including that acquired in the CMS merger) and damage' claims in excess of $200,000 proffered six representatives to be “lead Plaintiffs.” With the exception of a group of the four firms which represented Plaintiff Barry Baskin (the “Baskin group”), all counsel for Plaintiffs joined in the motion to appoint lead Plaintiffs and for the selection of Milberg Wbiss Bershad Bynes & Leraeh LLP (“Mil-berg Weiss”) and Barrack, Rodos & Baeine (“Barrack”) as co-lead counsel.

Following a hearing on June 26, 1996, the Court consolidated the related cases and appointed the six proffered Plaintiffs as lead Plaintiffs to represent the interests of the Class. 1 The Court appointed Alan Schulman of Milberg Weiss as lead counsel for Plaintiffs and two local attorneys, David Freedman and one of the Baskin counsel, Turner Branch, as co-liaison counsel.

After Horizon, settled the claims by the United States for the retroactive Medicare billings, HealthSouth Corporation became interested in acquiring Horizon. However, the pending legal action was a major impediment to such an acquisition. Horizon therefore approached lead counsel and negotiated a $17,000,000 cash settlement of the class action claims against Horizon only. The claims against the individuals were left pending but with high-low damage caps proposed. As part of the,settlement, Plaintiffs and Defendants agreed to the certification of classes and submitted the Settlement Agreement to the Court for approval.

In the notice of the proposed settlement, lead counsel reserved the right to request up to one-third in attorneys’ fees. Two of the largest class members, the State of Wisconsin Investment Board (“SWIB”) and the Colorado Public Employees Retirement Association (collectively “State Funds”), objected and recommended 17.5% as the appropriate benchmark for attorneys’ fees. Lead counsel requested attorneys’ fees in the amount of 25% of the settlement recovery.

After reviewing substantial briefs, and other submissions, the Court held a hearing on the settlement proposal on September 12, 1997. The Court recognized the Tenth Circuit Court of Appeals has expressed a general preference for awarding attorneys’ fees through the percentage method 2 and adopted that over the lodestar approach. 3 However, the Court was also aware the Tenth Circuit had frequently approved a percentage substantially below the standard one-third contingency fee, and that it has required attorneys’ fees have some correlation to the common benefit achieved for the Class. 4

*1212

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Haggart v. United States
Federal Claims, 2020
In Re New Mexico Indirect Purchasers Microsoft Corp.
2007 NMCA 007 (New Mexico Court of Appeals, 2006)
In Re Vitamins Antitrust Litigation
398 F. Supp. 2d 209 (District of Columbia, 2005)
RAMAH NAVAJO CHAPTOR v. Norton
250 F. Supp. 2d 1303 (D. New Mexico, 2002)
Mogell v. Franklin
219 F. Supp. 2d 657 (W.D. Pennsylvania, 2002)
In Re Westinghouse Securities Litigation
219 F. Supp. 2d 657 (W.D. Pennsylvania, 2002)
In Re Copley Pharmaceutical, Inc.
50 F. Supp. 2d 1141 (D. Wyoming, 1999)
Ramah Navajo Chapter v. Babbitt
50 F. Supp. 2d 1091 (D. New Mexico, 1999)
In re Baan Co. Securities Litigation
186 F.R.D. 214 (District of Columbia, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
3 F. Supp. 2d 1208, 1998 U.S. Dist. LEXIS 5785, 1998 WL 230234, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-horizoncms-healthcare-corp-securities-litigation-nmd-1998.